Cargando…

Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation

Malignant mesothelioma (MM) is a rare type of cancer primarily affecting mesothelial cells lining the pleural cavity. In this study, we propose to repurpose quinacrine (QA), a widely approved anti-malarial drug, for Malignant Pleural Mesothelioma (MPM) treatment. QA demonstrates high degree of cytot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulkarni, Nishant S., Vaidya, Bhuvaneshwar, Parvathaneni, Vineela, Bhanja, Debarati, Gupta, Vivek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503636/ https://www.ncbi.nlm.nih.gov/pubmed/32878257 http://dx.doi.org/10.3390/ijms21176306

Ejemplares similares

Exploring Amodiaquine’s Repurposing Potential in Breast Cancer Treatment—Assessment of In-Vitro Efficacy & Mechanism of Action
por: Parvathaneni, Vineela, et al.
Publicado: (2022)

Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges
por: Parvathaneni, Vineela, et al.
Publicado: (2020)

Therapeutic potential of inhalable medications to combat coronavirus disease-2019
por: Parvathaneni, Vineela, et al.
Publicado: (2020)

Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease
por: Lane, Thomas R., et al.
Publicado: (2020)

Repurposing the anti-malarial drug, quinacrine: new anti-colitis properties
por: Chumanevich, Alexander A., et al.
Publicado: (2016)

Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer
por: Shukla, Snehal K., et al.
Publicado: (2019)

The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CL(pro) In Vitro
por: Eberle, Raphael J., et al.
Publicado: (2021)

Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment
por: Parvathaneni, Vineela, et al.
Publicado: (2020)

Quinacrine Has Preferential Anticancer Effects on Mesothelioma Cells With Inactivating NF2 Mutations
por: Oien, Derek B., et al.
Publicado: (2021)

Parenteral Quinacrine in Malarial Fevers
por: Basumullick, K. L., et al.
Publicado: (1947)

ATRT-05. REPURPOSED ANTI-MALARIAL QUINACRINE ACTIVATES P53 AND INHIBITS ATRT TUMORIGENICITY
por: Kaur, Harpreet, et al.
Publicado: (2021)

Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes
por: Parvathaneni, Vineela, et al.
Publicado: (2021)

Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms
por: Puhl, Ana C., et al.
Publicado: (2020)

Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms
por: Puhl, Ana C., et al.
Publicado: (2021)

Development and Characterization of Folic Acid-Conjugated Amodiaquine-Loaded Nanoparticles–Efficacy in Cancer Treatment
por: Parvathaneni, Vineela, et al.
Publicado: (2023)

Treatment of Oriental Sore with Quinacrine
por: Sachdeva, Y. V.
Publicado: (1943)

Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma
por: Bryant, Jennifer, et al.
Publicado: (2019)

Discovery of Quinacrine as a Potent Topo II and Hsp90 Dual-Target Inhibitor, Repurposing for Cancer Therapy
por: Pan, Xin, et al.
Publicado: (2022)

Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
por: Boyer, Arnaud, et al.
Publicado: (2018)

Pharmacokinetics of quinacrine in the treatment of prion disease
por: Yung, Lotus, et al.
Publicado: (2004)

Toxic Symptoms Associated with Quinacrine Treatment
por: Nandi, D. K.
Publicado: (1947)

Quinacrine in the Eradication of Giardia Lamblia Infection
por: Pant, K. C., et al.
Publicado: (1942)

Quinacrine Treatment of Nitroimidazole-Refractory Giardiasis
por: Ydsten, Karin A, et al.
Publicado: (2021)

Influence of quinacrine and chloroquine on the in vitro 3′-azido-3′-deoxythymidine antiretroviral effect
por: Torres, Klintsy J, et al.
Publicado: (2015)

Candidate drug replacements for quinacrine in cutaneous lupus erythematosus
por: Yan, Daisy, et al.
Publicado: (2020)

Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine
por: Vignaux, Patricia A., et al.
Publicado: (2023)

Enhancement of paclitaxel activity against hormone-refractory prostate cancer cells in vitro and in vivo by quinacrine.
por: de Souza, P. L., et al.
Publicado: (1997)

Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
por: Moro, Jacopo, et al.
Publicado: (2022)

Continuous Quinacrine Treatment Results in the Formation of Drug-Resistant Prions
por: Ghaemmaghami, Sina, et al.
Publicado: (2009)

Quinacrine, an Old Drug with Potentially usefull in the Treatment for COVID-19
por: PINEDA, BENJAMIN
Publicado: (2021)

Multimodal Investigation into the Interaction of Quinacrine with Microcavity-Supported Lipid Bilayers
por: Sarangi, Nirod Kumar, et al.
Publicado: (2022)

Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro
por: Salas Rojas, Mónica, et al.
Publicado: (2021)

Malignant mesothelioma
por: Ruffié, P, et al.
Publicado: (2001)

Malignant mesothelioma
por: Moore, Alastair J, et al.
Publicado: (2008)

Malignant mesothelioma
por: Ahmed, Ishtiaq, et al.
Publicado: (2013)

Malignant Mesothelioma
por: Pouliquen, Daniel L., et al.
Publicado: (2021)

Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives
por: Boussios, Stergios, et al.
Publicado: (2018)

The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma
por: Oguh-Olayinka, Lily, et al.
Publicado: (2019)

The therapeutic implications of the genomic analysis of malignant pleural mesothelioma
por: Zauderer, Marjorie G.
Publicado: (2021)

An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
por: Davis, Alexander, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_79bd4g3cmh4dva0ts975sr09kh